{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,22]],"date-time":"2026-03-22T03:56:27Z","timestamp":1774151787136,"version":"3.50.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,1,11]],"date-time":"2017-01-11T00:00:00Z","timestamp":1484092800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100007880","name":"Johns Hopkins University","doi-asserted-by":"publisher","award":["2002129112"],"award-info":[{"award-number":["2002129112"]}],"id":[{"id":"10.13039\/100007880","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1007\/s11060-016-2351-2","type":"journal-article","created":{"date-parts":[[2017,1,11]],"date-time":"2017-01-11T08:22:06Z","timestamp":1484122926000},"page":"135-143","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Development of the pediatric quality of life inventory neurofibromatosis type 1 module items for children, adolescents and young adults: qualitative methods"],"prefix":"10.1007","volume":"132","author":[{"given":"Kavitha","family":"Nutakki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James W.","family":"Varni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheila","family":"Steinbrenner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire B.","family":"Draucker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy L.","family":"Swigonski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,1,11]]},"reference":[{"issue":"1","key":"2351_CR1","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1542\/peds.2007-3204","volume":"123","author":"VC Williams","year":"2009","unstructured":"Williams VC et al (2009) Neurofibromatosis type 1 revisited. Pediatrics 123(1):124\u2013133","journal-title":"Pediatrics"},{"issue":"2","key":"2351_CR2","first-page":"E47","volume":"6","author":"C Lu-Emerson","year":"2009","unstructured":"Lu-Emerson C, Plotkin SR (2009) The Neurofibromatoses. Part 1: NF1. Rev Neurol Dis 6(2):E47\u2013E53","journal-title":"Rev Neurol Dis"},{"issue":"1","key":"2351_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1096-8628(19990326)89:1<1::AID-AJMG3>3.0.CO;2-8","volume":"89","author":"JM Friedman","year":"1999","unstructured":"Friedman JM (1999) Epidemiology of neurofibromatosis type 1. Am J Med Genet 89(1):1\u20136","journal-title":"Am J Med Genet"},{"issue":"8","key":"2351_CR4","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1177\/088307380201700802","volume":"17","author":"JM Friedman","year":"2002","unstructured":"Friedman JM (2002) Neurofibromatosis 1: clinical manifestations and diagnostic criteria. J Child Neurol 17(8):548\u2013554 (discussion 571\u2013572, 646\u2013651)","journal-title":"J Child Neurol"},{"issue":"11\u201312","key":"2351_CR5","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s10354-005-0185-1","volume":"155","author":"K Wimmer","year":"2005","unstructured":"Wimmer K (2005) Neurofibromatosis: the most frequent hereditary tumor predisposition syndrome. Wien Med Wochenschr 155(11\u201312):273\u2013280","journal-title":"Wien Med Wochenschr"},{"issue":"1","key":"2351_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/GIM.0b013e3181bf15e3","volume":"12","author":"K Jett","year":"2010","unstructured":"Jett K, Friedman JM (2010) Clinical and genetic aspects of neurofibromatosis 1. Genet Med 12(1):1\u201311","journal-title":"Genet Med"},{"key":"2351_CR7","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/B978-0-444-62702-5.00004-4","volume":"132","author":"JL Anderson","year":"2015","unstructured":"Anderson JL, Gutmann DH (2015) Neurofibromatosis type 1. Handb Clin Neurol 132:75\u201386","journal-title":"Handb Clin Neurol"},{"issue":"5","key":"2351_CR8","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1136\/jmg.39.5.311","volume":"39","author":"DG Evans","year":"2002","unstructured":"Evans DG et al (2002) Malignant peripheral nerve sheath tumours in neurofibromatosis 1. J Med Genet 39(5):311\u2013314","journal-title":"J Med Genet"},{"key":"2351_CR9","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/B978-0-444-52902-2.00053-9","volume":"115","author":"RE Ferner","year":"2013","unstructured":"Ferner RE, Gutmann DH (2013) Neurofibromatosis type 1 (NF1): diagnosis and management. Handb Clin Neurol 115:939\u2013955","journal-title":"Handb Clin Neurol"},{"issue":"6","key":"2351_CR10","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s11940-015-0355-4","volume":"17","author":"C Sabatini","year":"2015","unstructured":"Sabatini C et al (2015) Treatment of neurofibromatosis type 1. Curr Treat Options Neurol 17(6):355","journal-title":"Curr Treat Options Neurol"},{"issue":"1","key":"2351_CR11","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/MOP.0000000000000169","volume":"27","author":"MA Karajannis","year":"2015","unstructured":"Karajannis MA, Ferner RE (2015) Neurofibromatosis-related tumors: emerging biology and therapies. Curr Opin Pediatr 27(1):26\u201333","journal-title":"Curr Opin Pediatr"},{"issue":"12","key":"2351_CR12","first-page":"1441","volume":"140","author":"GH Guyatt","year":"1989","unstructured":"Guyatt GH et al (1989) Measuring quality of life in clinical trials: a taxonomy and review. Cmaj 140(12):1441\u20131448","journal-title":"Cmaj"},{"issue":"2","key":"2351_CR13","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s11060-015-1725-1","volume":"122","author":"AM Vranceanu","year":"2015","unstructured":"Vranceanu AM et al (2015) Quality of life among children and adolescents with neurofibromatosis 1: a systematic review of the literature. J Neurooncol 122(2):219\u2013228","journal-title":"J Neurooncol"},{"issue":"3","key":"2351_CR14","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s11060-013-1195-2","volume":"114","author":"AM Vranceanu","year":"2013","unstructured":"Vranceanu AM et al (2013) Quality of life among adult patients with neurofibromatosis 1, neurofibromatosis 2 and schwannomatosis: a systematic review of the literature. J Neurooncol 114(3):257\u2013262","journal-title":"J Neurooncol"},{"key":"2351_CR15","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3899\/jrheum.110906","volume":"88","author":"GA Wells","year":"2011","unstructured":"Wells GA et al (2011) Validity of quality of life measurement tools\u2014from generic to disease-specific. J Rheumatol Suppl 88:2\u20136","journal-title":"J Rheumatol Suppl"},{"key":"2351_CR16","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1477-7525-11-21","volume":"11","author":"K Nutakki","year":"2013","unstructured":"Nutakki K et al (2013) Development of the adult PedsQL neurofibromatosis type 1 module: initial feasibility, reliability and validity. Health Qual Life Outcomes 11:21","journal-title":"Health Qual Life Outcomes"},{"issue":"8","key":"2351_CR17","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1007\/s11136-010-9677-6","volume":"19","author":"KE Lasch","year":"2010","unstructured":"Lasch KE et al (2010) PRO development: rigorous qualitative research as the crucial foundation. Qual Life Res 19(8):1087\u20131096","journal-title":"Qual Life Res"},{"issue":"9","key":"2351_CR18","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1007\/s11136-009-9540-9","volume":"18","author":"M Brod","year":"2009","unstructured":"Brod M, Tesler LE, Christensen TL (2009) Qualitative research and content validity: developing best practices based on science and experience. Qual Life Res 18(9):1263\u20131278","journal-title":"Qual Life Res"},{"key":"2351_CR19","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1477-7525-7-3","volume":"7","author":"DE Irwin","year":"2009","unstructured":"Irwin DE et al (2009) Cognitive interviewing methodology in the development of a pediatric item bank: a patient reported outcomes measurement information system (PROMIS) study. Health Qual Life Outcomes 7:3","journal-title":"Health Qual Life Outcomes"},{"key":"2351_CR20","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1477-7525-4-79","volume":"4","author":"U.S. Department of Health and Human Services FDA Center for Drug Evaluation and Research","year":"2006","unstructured":"U.S. Department of Health and Human Services FDA Center for Drug Evaluation and Research, U.S. Department of Health and Human Services FDA Center for Biologics Evaluation and Research, Department of Health and Human Services FDA Center for Devices and Radiological Health (2006) Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health Qual Life Outcomes 4:79","journal-title":"Health Qual Life Outcomes"},{"issue":"5","key":"2351_CR21","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1097\/MPG.0b013e31823c9b88","volume":"54","author":"JW Varni","year":"2012","unstructured":"Varni JW et al (2012) PedsQL gastrointestinal symptoms module item development: qualitative methods. J Pediatr Gastroenterol Nutr 54(5):664\u2013671","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"2","key":"2351_CR22","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s11136-011-9941-4","volume":"21","author":"JA Panepinto","year":"2012","unstructured":"Panepinto JA, Torres S, Varni JW (2012) Development of the PedsQL sickle cell disease module items: qualitative methods. Qual Life Res 21(2):341\u2013357","journal-title":"Qual Life Res"},{"key":"2351_CR23","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-230X-12-135","volume":"12","author":"JP Franciosi","year":"2012","unstructured":"Franciosi JP et al (2012) Development of the pediatric quality of life inventory eosinophilic esophagitis module items: qualitative methods. BMC Gastroenterol 12:135","journal-title":"BMC Gastroenterol"},{"issue":"6","key":"2351_CR24","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1017\/S001216220600096X","volume":"48","author":"JW Varni","year":"2006","unstructured":"Varni JW et al (2006) The PedsQL in pediatric cerebral palsy: reliability, validity, and sensitivity of the generic core scales and cerebral palsy module. Dev Med Child Neurol 48(6):442\u2013449","journal-title":"Dev Med Child Neurol"},{"issue":"3","key":"2351_CR25","doi-asserted-by":"crossref","first-page":"631","DOI":"10.2337\/diacare.26.3.631","volume":"26","author":"JW Varni","year":"2003","unstructured":"Varni JW et al (2003) The PedsQL in type 1 and type 2 diabetes: reliability and validity of the pediatric quality of life inventory generic core scales and type 1 diabetes module. Diabetes Care 26(3):631\u2013637","journal-title":"Diabetes Care"},{"issue":"7","key":"2351_CR26","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1002\/cncr.10428","volume":"94","author":"JW Varni","year":"2002","unstructured":"Varni JW et al (2002) The PedsQL in pediatric cancer: reliability and validity of the Pediatric Quality of Life Inventory Generic Core Scales, Multidimensional Fatigue Scale, and Cancer Module. Cancer 94(7):2090\u20132106","journal-title":"Cancer"},{"issue":"3","key":"2351_CR27","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/art.10095","volume":"46","author":"JW Varni","year":"2002","unstructured":"Varni JW et al (2002) The PedsQL in pediatric rheumatology: reliability, validity, and responsiveness of the Pediatric Quality of Life Inventory Generic Core Scales and Rheumatology Module. Arthritis Rheum 46(3):714\u2013725","journal-title":"Arthritis Rheum"},{"issue":"3","key":"2351_CR28","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1023\/B:JOBM.0000028500.53608.2c","volume":"27","author":"JW Varni","year":"2004","unstructured":"Varni JW et al (2004) The PedsQL in pediatric asthma: reliability and validity of the Pediatric Quality of Life Inventory generic core scales and asthma module. J Behav Med 27(3):297\u2013318","journal-title":"J Behav Med"},{"issue":"2","key":"2351_CR29","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1053\/j.ajkd.2007.09.021","volume":"51","author":"SL Goldstein","year":"2008","unstructured":"Goldstein SL et al (2008) Measuring health-related quality of life in children with ESRD: performance of the generic and ESRD-specific instrument of the Pediatric Quality of Life Inventory (PedsQL). Am J Kidney Dis 51(2):285\u2013297","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"2351_CR30","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/pbc.21026","volume":"49","author":"SN Palmer","year":"2007","unstructured":"Palmer SN et al (2007) The PedsQL Brain Tumor Module: initial reliability and validity. Pediatr Blood Cancer 49(3):287\u2013293","journal-title":"Pediatr Blood Cancer"},{"issue":"7","key":"2351_CR31","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1111\/j.1600-6143.2010.03149.x","volume":"10","author":"J Weissberg-Benchell","year":"2010","unstructured":"Weissberg-Benchell J et al (2010) Pediatric health-related quality of life: Feasibility, reliability and validity of the PedsQL transplant module. Am J Transplant 10(7):1677\u20131685","journal-title":"Am J Transplant"},{"key":"2351_CR32","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.yebeh.2016.06.011","volume":"62","author":"KW Follansbee-Junger","year":"2016","unstructured":"Follansbee-Junger KW et al (2016) Development of the PedsQL Epilepsy Module: Focus group and cognitive interviews. Epilepsy Behav 62:115\u2013120","journal-title":"Epilepsy Behav"},{"issue":"8","key":"2351_CR33","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1007\/s11136-012-0339-8","volume":"22","author":"JW Varni","year":"2013","unstructured":"Varni JW et al (2013) Content validity of the PedsQL 3.2 Diabetes Module in newly diagnosed patients with Type 1 diabetes mellitus ages 8\u201345. Qual Life Res 22(8):2169\u20132181","journal-title":"Qual Life Res"},{"key":"2351_CR34","unstructured":"Varni JW The PedsQL measurement model for the pediatric quality of life inventory. PedsQL 1998\u20132016 [cited 2016 May 27]. http:\/\/www.pedsql.org\/"},{"key":"2351_CR35","unstructured":"PROMIS Measures cited 2016. http:\/\/www.nihpromis.org\/measures\/selectinginstrument"},{"key":"2351_CR36","unstructured":"NeuroQOL 2013 cited 2016. http:\/\/www.neuroqol.org\/WhatandWhy\/BankDevelopment\/Pages\/default.aspx"},{"issue":"6","key":"2351_CR37","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","volume":"30","author":"JE Ware Jr","year":"1992","unstructured":"Ware JE Jr, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30(6):473\u2013483","journal-title":"Med Care"},{"issue":"2","key":"2351_CR38","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.det.2011.11.003","volume":"30","author":"MM Chren","year":"2012","unstructured":"Chren MM (2012) The Skindex instruments to measure the effects of skin disease on quality of life. Dermatol Clin 30(2):231\u2013236 (xiii)","journal-title":"Dermatol Clin"},{"issue":"6","key":"2351_CR39","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1111\/j.1365-2133.1995.tb16953.x","volume":"132","author":"MS Lewis-Jones","year":"1995","unstructured":"Lewis-Jones MS, Finlay AY (1995) The Children\u2019s Dermatology Life Quality Index (CDLQI): initial validation and practical use. Br J Dermatol 132(6):942\u2013949","journal-title":"Br J Dermatol"},{"issue":"4","key":"2351_CR40","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0892-1997(99)80010-1","volume":"13","author":"ND Hogikyan","year":"1999","unstructured":"Hogikyan ND, Sethuraman G (1999) Validation of an instrument to measure voice-related quality of life (V-RQOL). J Voice 13(4):557\u2013569","journal-title":"J Voice"},{"issue":"7","key":"2351_CR41","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1002\/hed.20795","volume":"30","author":"RN Rinkel","year":"2008","unstructured":"Rinkel RN et al (2008) Speech Handicap Index in patients with oral and pharyngeal cancer: better understanding of patients\u2019 complaints. Head Neck 30(7):868\u2013874","journal-title":"Head Neck"},{"issue":"9","key":"2351_CR42","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1007\/s11136-013-0365-1","volume":"22","author":"SH Paz","year":"2013","unstructured":"Paz SH et al (2013) Development of a vision-targeted health-related quality of life item measure. Qual Life Res 22(9):2477\u20132487","journal-title":"Qual Life Res"},{"issue":"5 Suppl 1","key":"2351_CR43","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1097\/01.mlr.0000254567.79743.e2","volume":"45","author":"DA DeWalt","year":"2007","unstructured":"DeWalt DA et al (2007) Evaluation of item candidates: the PROMIS qualitative item review. Med Care 45(5 Suppl 1):S12\u2013S21","journal-title":"Med Care"},{"issue":"11","key":"2351_CR44","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.jpain.2010.02.005","volume":"11","author":"JW Varni","year":"2010","unstructured":"Varni JW et al (2010) PROMIS Pediatric Pain Interference Scale: an item response theory analysis of the pediatric pain item bank. J Pain 11(11):1109\u20131119","journal-title":"J Pain"},{"issue":"4","key":"2351_CR45","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s11136-010-9618-4","volume":"19","author":"DE Irwin","year":"2010","unstructured":"Irwin DE et al (2010) Sampling plan and patient characteristics of the PROMIS pediatrics large-scale survey. Qual Life Res 19(4):585\u2013594","journal-title":"Qual Life Res"},{"issue":"3","key":"2351_CR46","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3109\/02770900903426997","volume":"47","author":"KB Yeatts","year":"2010","unstructured":"Yeatts KB et al (2010) Construction of the Pediatric Asthma Impact Scale (PAIS) for the Patient-Reported Outcomes Measurement Information System (PROMIS). J Asthma 47(3):295\u2013302","journal-title":"J Asthma"},{"issue":"4","key":"2351_CR47","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s11136-010-9619-3","volume":"19","author":"DE Irwin","year":"2010","unstructured":"Irwin DE et al (2010) An item response analysis of the pediatric PROMIS anxiety and depressive symptoms scales. Qual Life Res 19(4):595\u2013607","journal-title":"Qual Life Res"},{"issue":"1","key":"2351_CR48","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0304-3959(87)91056-6","volume":"28","author":"JW Varni","year":"1987","unstructured":"Varni JW, Thompson KL, Hanson V (1987) The Varni\/Thompson Pediatric Pain Questionnaire. I. Chronic musculoskeletal pain in juvenile rheumatoid arthritis. Pain 28(1):27\u201338","journal-title":"Pain"},{"key":"2351_CR49","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1477-7525-5-43","volume":"5","author":"JW Varni","year":"2007","unstructured":"Varni JW, Limbers CA, Burwinkle TM (2007) Impaired health-related quality of life in children and adolescents with chronic conditions: a comparative analysis of 10 disease clusters and 33 disease categories\/severities utilizing the PedsQL 4.0 Generic Core Scales. Health Qual Life Outcomes 5:43","journal-title":"Health Qual Life Outcomes"},{"issue":"1","key":"2351_CR50","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1177\/1525822X05279903","volume":"18","author":"G Guest","year":"2006","unstructured":"Guest G, Bunce A, Johnson L (2006) How many interviews are enough? An experiment with data saturation variability. Field Methods 18(1):59\u201382","journal-title":"Field Methods"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-016-2351-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-016-2351-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-016-2351-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T03:57:02Z","timestamp":1498363022000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-016-2351-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,11]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["2351"],"URL":"https:\/\/doi.org\/10.1007\/s11060-016-2351-2","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,11]]}}}